March 1, 2006 "Common antibiotic dangerous, Canadian study shows"
July 15, 2005 Fluoroquinolones and thrombocytopenia
July 14, 2005 Health Canada issues advisory over statins
June 24, 2005 Cipro & Mutation Rates
June 23, 2005 Hepatitis & Paxil
June 22, 2005 MSF and Prenatal Exposure
June 16, 2005 Ban of School Lunch Program w/fluoroquinolones
June 15, 2005 UPI honored for GI malaria-drug reporting
June 2, 2005 Lariam and Iraq Casualties
May 28, 2005 New Research Confirms Crestor Adverse Effects
May 24, 2005 Recent Research: Fluoroquinolones & Apoptosis
May 18, 2005 Pregnancy warning on Anti-depressants
May 2, 2005 Prozac & Sexualtity
April 29, 2005 Another “Paxil Defense” Case
April 27, 2005 Lawyer Says Prozac To Blame for Triple Murder
April 26, 2005 Britain to clash with Europe over Prozac
April 17, 2005 Paxil & Hyponatremia
April 15, 2005 GSK Investors bring Paxil lawsuit
April 9, 2005 Fluoroquinolones and C.Difficile
March 27, 2005 Recent Research: Prozac and G proteins
March 26, 2005 Family Wonders if Prozac Prompted School Shootings
March 21, 2005 Fluoroquinolones & Resistance
March 15, 2005 FDA rejects Crestor petition
March 11, 2005 FDA warns AstraZeneca on Crestor again
March 10, 2005 Crestor warnings too weak, group says
March 6, 2005 Health Canada issues Crestor warning
March 5, 2005 Iressa not performing
March 5, 2005 FDA seizes Paxil CR
March 4, 2005 Lariam increases psychiatric events
March 3, 2005 Black Box warning now in effect
February 16, 2005 Side-effect reports cast shadow over malaria drug
February 11, 2005 Another violent Lariam suicide
February 10, 2005 Celebrex to carry warning
February 4, 2005 Antidepressants Linked to Withdrawals in Newborns, Study Says
January 31, 2005 Consumer Group Says Pfizer Hid Celebrex Study
January 26, 2005 GlaxoSmithKline: Deadly Depressing
January 20, 2005 Pfizer Gets European Request for More Celebrex Data
January 16, 2005 A shadow of doubt
January 16, 2005 New Prozac Blues Dutch study raises new concerns for some users
January 14, 2005 Prozac: A class action lawsuit is filed in Montreal
January 13, 2005 Celebrex Ads Were Misleading, FDA Says
January 11, 2005 Crestor death link confirmed
January 10, 2005 Prozac risk for young brains
January 5, 2005 Lilly attacks BMJ's Prozac claims
January 4, 2005 Prozac and Paxil interfere with Tamoxifen
January 3, 2005 Pfizer sued over Celebrex
December 31, 2004 FDA to review "missing" drug company documents
December 30, 2004 Prozac Maker Knew of Problems in 1988
December 28, 2004 Painkiller causes death in dogs
December 21, 2004 German doctors advise patients not to use Celebrex
December 18, 2004 Third AstraZeneca Drug Found Wanting
December 17, 2004 Celebrex seen raising risk of heart disease
December 16, 2004 Busting Big Pharma
December 9, 2004 Drug maker Witheld Paxil Study Data
December 8, 2004 Paxil and perinatal complications
December 8, 2004 Crestor ads draw fire; FDA could act
December 6, 2004 UK GP’s get new anti-depressant rules
December 4, 2004 Europeans study Crestor Safety
December 3 , 2004 Antidepressant Use By U.S. Adults Soars
November 30 FDA Grants Approval for Factive(R) (gemifloxacin) in spite of fluoroquinolones being associated with irreversible Peripheral Neuropathy
November 28, 2004 Belgians turning into Prozac junkies
November 27, 2004 Bayer Could Face Criminal Investigation
November 26, 2004 Drugs to fight depression may trigger bleeding
November 21, 2004 Trial finds that Prozac may stunt children's growth
November 16, 2004 Prozac inhibits metamorphosis
November 13, 2004 Prozac found in Canada’s drinking water
November 11, 2004 Prozac impairs bone growth
November 7, 2004 Secret plan to push “Happy Pills”
November 4, 2004 Celebrex tied to 14 deaths in Canada
October 29, 2004 Prozac use 'risky for children'
Mums-To-Be Prozac Fear
October 25, 2004 "Prozac: Tool of Evil or Heaven in a Pill?"
October 15, 2004 FDA orders “Black Box” warning
October 9, 2004 Lariam: The New Agent Orange?
October 4, 2004 “Drug Industry Scandal a ‘Crisis’”
September 29, 2004 “Sales reps told not to divulge Paxil data”
September 28, 2004 “FDA to Study Suicide Risks in Adults”
September 23, 2004 “FDA epidemiologist says agency pressured him on antidepressants” (Black Box warning coming...)
September 13, 2004 “Prozac also linked to child suicide risk”
September 7, 2004 “Hearing on Antidepressants - Sept.9”
September 6, 2004 “American parents sue GSK over Seroxat”
August 27, 2004 Consumer Watch: Suit Alleges Paxil Addiction
August 26, 2004 “Glaxo Settles Suit Over Paxil Studies”
August 20, 2004 “Antidepressant Study Seen to Back Expert”
August 10, 2004 “Pregnant women warned about anti-depressants”
August 8, 2004 “Prozac seeping into water supplies” The Scotsman
====================
August 4, 2004 “Watchdog wants Crestor probe”
===============
July 24, 2004 “Maker of drug admits hiding its risks”
==============
July 13, 2004 “Bayer Will Pay $1.06 Billion to Settle 2,771 Baycol Lawsuits”
==============
July 10, 2004 “Agency says U.S. researcher was consultant to Crestor maker” Newsday - July 10, 2004
One week after cholesterol-reducing Crestor was approved last year, a top government researcher published a scientific paper praising the medication, but failed to mention he was a consultant to the drug's maker, a watchdog group has charged in a letter to the nation's top health agency. Read more...
June 19, 2004 “Health Canada warns of cholesterol drug risks” Canadian Press
Today Health Canada issued a drug warning concerning AstraZeneca’s “Crestor” (rosuvastatin) because it causes rhabdomyolysis. It is another statin drug - just like Baycol - with a fluorophenyl compound. Read more...
========================
June 11, 2004 “FDA Warns Glaxo Over Paxil” Dow Jones Newswires
June 2, 2004 New York Sues Maker of Antidepressant Drug Paxil
==========================
April 16, 2004 FDA was urged to limit kids' antidepressants Advice citing risk of suicide rejected
April 16, 2004 -- A medical reviewer at the Food and Drug Administration recommended earlier this year that the agency adopt a tough "risk management strategy" urging doctors to stop prescribing most antidepressants to children, but the FDA rejected his advice and instead asked drug companies only to warn patients and doctors about possible risks to young patients, The Chronicle has learned. Read more
========================
Februray 26, 2004 “US Army Study to Dispel Lariam Suicide Myths”
WASHINGTON, February 26, 2004 –- The surgeon general of the Army told Congress that there is no correlation between the anti-malaria drug Lariam and a recent spike in suicides in combat zones.” Read more...
========================
February 8, 2004 “$90m payout over child abuse”
February 1, 2004 “Child abuse probe uncovers deadly role of axed drug”
February 1, 2004 “How I lost two children to the 'lie' of Munchausen's”
=======================
October 31, 2003 "Scientists find that Prozac inhibits metamorphosis in tadpoles"
ATHENS, Ga. October 31, 2003 - - University of Georgia researchers have discovered developmental problems in frogs and fish exposed to minute quantities of common antidepressants that can pass from humans through sewage treatment systems into rivers and streams. Read more
========================
September 21, 2003 “Watchdog bans 14 prescription drugs over fear of multiple deaths”
September 21, 2003 -- Britain's drug watchdog has been forced to ban the use of 14 prescription drugs in the last five years after they were suspected of killing hundreds of people in the UK or harming thousands through serious side effects. Read more
=====================
June 19th, 2003: FDA Statement Regarding the Anti-Depressant Paxil for Pediatric Population
The Food and Drug Administration (FDA) said today it is reviewing reports of a possible increased risk of suicidal thinking and suicide attempts in children and adolescents under the age of 18 treated with the drug Paxil for major depressive disorder (MDD). Read more...
June 10, 2003: Seroxat must not be used for treatment of children
New expert advice recommends that the drug Seroxat(paroxetine) is not used to treat children and teenagers under the age of 18 years, for depressive illness, said Professor Alasdair Breckenridge, Chairman of the Medicines and Healthcare products Regulatory Agency. Read more...
========================
|